Dopamine agonists (DA) are the cornerstone treatment for prolactinomas, resulting in the normalization of prolactin (PRL) levels, adenoma shrinkage, and restoration of gonadal function [2]. Here, PRL is linked to prolactin-producing pituitary gland adenoma.